These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 19651473)

  • 1. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.
    Wen KW; Damania B
    Cancer Lett; 2010 Mar; 289(2):140-50. PubMed ID: 19651473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research].
    Watanabe T; Fujimuro M
    Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRX1 negatively modulates type I IFN to facilitate KSHV reactivation from latency.
    Ma Z; Hopcraft SE; Yang F; Petrucelli A; Guo H; Ting JP; Dittmer DP; Damania B
    PLoS Pathog; 2017 May; 13(5):e1006350. PubMed ID: 28459883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
    Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
    mBio; 2018 May; 9(3):. PubMed ID: 29739902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linking KSHV to human cancer.
    Wong EL; Damania B
    Curr Oncol Rep; 2005 Sep; 7(5):349-56. PubMed ID: 16091195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KSHV Genome Replication and Maintenance in Latency.
    Ueda K
    Adv Exp Med Biol; 2018; 1045():299-320. PubMed ID: 29896673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNAs and their roles in KSHV pathogenesis.
    Hussein HAM; Alfhili MA; Pakala P; Simon S; Hussain J; McCubrey JA; Akula SM
    Virus Res; 2019 Jun; 266():15-24. PubMed ID: 30951791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ORF45 Protein of Kaposi Sarcoma-Associated Herpesvirus Is an Inhibitor of p53 Signaling during Viral Reactivation.
    Alzhanova D; Meyo JO; Juarez A; Dittmer DP
    J Virol; 2021 Nov; 95(23):e0145921. PubMed ID: 34523970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment.
    Gantt S; Casper C
    Curr Opin Infect Dis; 2011 Aug; 24(4):295-301. PubMed ID: 21666458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology.
    Li S; Bai L; Dong J; Sun R; Lan K
    Adv Exp Med Biol; 2017; 1018():91-127. PubMed ID: 29052134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi sarcoma herpesvirus-associated cancers and related diseases.
    Goncalves PH; Ziegelbauer J; Uldrick TS; Yarchoan R
    Curr Opin HIV AIDS; 2017 Jan; 12(1):47-56. PubMed ID: 27662501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.
    Schulz TF; Cesarman E
    Curr Opin Virol; 2015 Oct; 14():116-28. PubMed ID: 26431609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of KSHV Latency and Lytic Reactivation.
    Broussard G; Damania B
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32957532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammasome activation in patients with Kaposi sarcoma herpesvirus-associated diseases.
    Lage SL; Ramaswami R; Rocco JM; Rupert A; Davis DA; Lurain K; Manion M; Whitby D; Yarchoan R; Sereti I
    Blood; 2024 Oct; 144(14):1496-1507. PubMed ID: 38941593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent infection with Kaposi's sarcoma-associated herpesvirus enhances retrotransposition of long interspersed element-1.
    Nakayama R; Ueno Y; Ueda K; Honda T
    Oncogene; 2019 May; 38(22):4340-4351. PubMed ID: 30770900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's sarcoma-associated herpesvirus at 27.
    Gaglia MM
    Tumour Virus Res; 2021 Dec; 12():200223. PubMed ID: 34153523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders.
    Du MQ; Bacon CM; Isaacson PG
    J Clin Pathol; 2007 Dec; 60(12):1350-7. PubMed ID: 18042691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi sarcoma-associated herpesvirus complement control protein (KCP) and glycoprotein K8.1 are not required for viral infection
    Muniraju M; Mutsvunguma LZ; Reidel IG; Escalante GM; Cua S; Musonda W; Calero-Landa J; Farelo MA; Rodriguez E; Li Z; Ogembo JG
    J Virol; 2024 Jun; 98(6):e0057624. PubMed ID: 38767375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis.
    Yan L; Majerciak V; Zheng ZM; Lan K
    Virol Sin; 2019 Apr; 34(2):135-161. PubMed ID: 31025296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.